1-20 of 64
Andreas Neubauer, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-Risk Additional Chromosomal Abnormalities in CML Herald Death By Blast Crisis Already at Low Blast Levels

Rüdiger Hehlmann, MD, Astghik Voskanyan, Michael Lauseker, Markus Pfirrmann, PhD, Lida Kalmanti, Sébastien Rinaldetti, Katharina Kohlbrenner, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD, Alice Fabarius, PhD, Stefan W Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, MD PhD, Christoph Nerl, MD PhD, Alois Gratwohl, MD, Gabriela M Baerlocher, MD, Andreas Burchert, MD, Tim H Brümmendorf, MD, Andreas Hochhaus, MD, Susanne Saussele, MD, Michele Baccarani, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 666.
https://doi.org/10.1182/blood-2019-127127
Published: 2019
Journal Articles

Emerging Mutations at Relapse in Patients with FLT3 -Mutated Relapsed/Refractory Acute Myeloid Leukemia Who Received Gilteritinib Therapy in the Phase 3 Admiral Trial

Catherine C. Smith, MD, Mark J. Levis, MD, Alexander E. Perl, MD, Giovanni Martinelli, MD, Andreas Neubauer, MD, Ellin Berman, MD, Pau Montesinos, MD PhD, Maria R. Baer, MD, Richard A. Larson, MD, Wen-Chien Chou, MD, PhD, Hisayuki Yokoyama, MD PhD, Christian Recher, MD PhD, Sung-Soo Yoon, MD PhD, Jason E. Hill, Matt Rosales, Erkut Bahceci
Journal: Blood
Blood (2019) 134 (Supplement_1): 14.
https://doi.org/10.1182/blood-2019-122620
Published: 2019
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Pathological Hepatic Contrast-Enhanced Ultrasound (CEUS) Pattern in Patients Undergoing Allogeneic Stem Cell Transplantation (allo-SCT)

Corinna Trenker, MD, Andreas Burchert, MD, Christian Sebastian Michel, MD, Caren Schuhmacher, Student, Jonas A. Schäfer, MD, Marius Dohse, MD, Andreas Neubauer, MD, Kristina Sohlbach, MD, Christian Görg, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3359.
https://doi.org/10.1182/blood-2018-99-110479
Published: 2018
Journal Articles

The Genes for Tissue Factor F3 and Nuclear Receptor 4A Are Down-Regulated in Early Death Acute Promyelocytic Leukemia Patients

Miriam Frech, PhD, Kathleen Stabla, Andrea Nist, PhD, Marco Mernberger, PhD, Heidi Altmann, PhD, Uwe Platzbecker, Christian Thiede, MD, Prema Erramsetti, Sabine Teichler, PhD, Cornelia Brendel, MD, Richard F. Schlenk, MD, Thorsten Stiewe, MD, Andreas Neubauer, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3902.
https://doi.org/10.1182/blood-2018-99-112978
Published: 2018
Journal Articles

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Christoph Rollig, MD MSC, Hubert Serve, Andreas Hüttmann, MD, Richard Noppeney, MD, Carsten Müller-Tidow, Utz Krug, Claudia D. Baldus, MD, Christian H. Brandts, MD, Volker Kunzmann, MD PhD, Hermann Einsele, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Andreas Burchert, MD, Aristoteles Giagounidis, MD, Stefan W. Krause, Andreas Mackensen, MD, Walter E. Aulitzky, MD, Regina Herbst, MD, Mathias Hänel, MD, Alexander Kiani, Norbert Frickhofen, MD, Johannes Kullmer, Ulrich Kaiser, MD, Hartmut Link, MD PhD, Thomas Geer, MD, Albrecht Reichle, MD, Christian Junghanss, MD, Roland Repp, MD, Frank Heits, MD, Heinz Albert Durk, Thomas Illmer, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani Barbara Parmentier, MD, Martin Goerner, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD, Michael Kramer, M.Sc., Wolfgang E. Berdel, Gerhard Ehninger
Journal: Blood
Blood (2017) 130 (Supplement 1): 721.
https://doi.org/10.1182/blood.V130.Suppl_1.721.721
Published: 2017
Journal Articles

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Rüdiger Hehlmann, MD, Michael Lauseker, PhD, Susanne Saussele, MD, Markus Pfirrmann, Stefan W. Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, Christoph Nerl, MD, Alois Gratwohl, MD, Gabriela M. Baerlocher, Dominik Heim, MD, Tim Henrik Bruemmendorf, Alice Fabarius, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martin C. Müller, MD, Sabine Jeromin, PhD, Ulrike Proetel, PhD, Katharina Kohlbrenner, PhD, Astghik Voskanyan, PhD, Sébastien Rinaldetti, Wolfgang Seifarth, PhD, Birgit Spiess, Leopold Balleisen, MD, Maria E Goebeler, MD, Mathias Hänel, MD, Anthony D. Ho, MD, J Dengler, C Falge, Lothar Kanz, MD, Claus-Henning Köhne, MD, PhD, Andreas Burchert, MD, Michael Kneba, MD PhD, Frank Stegelmann, MD, C Köhne, Hans-Walter Lindemann, C Waller, Michael Pfreundschuh, MD, Karsten Spiekermann, Wolfgang E Berdel, MD, L Müller, Matthias Edinger, MD, Jiri Mayer, Prof, MD SCs, Dietrich W Beelen, MD PhD, Martin Bentz, MD, Hartmut Link, MDPhD, Bernd Hertenstein, MD, R Fuchs, Martin Wernli, MD, F Schlegel, Rudolph Schlag, M de Wit, Lorenz Trümper, MD, H Hebarth, M Hahn, Jörg Thomalla, MD, Christof Scheid, MD, Philippe Schafhausen, MD, Walter Verbeek, MD, Michael J. Eckart, MD, Winfried Gassmann, MD PhD, Antonio Pezzutto, MD, Michael Schenk, Peter Brossart, MD, Thomas Geer, MD, Stephan Bildat, E Schäfer, Andreas Hochhaus, MD, Joerg Hasford
Journal: Blood
Blood (2017) 130 (Supplement 1): 897.
https://doi.org/10.1182/blood.V130.Suppl_1.897.897
Published: 2017
Journal Articles

Real World Data on Decitabine Treatment in 296 Patients with Acute Myeloid Leukemia: Outcome and Impact of TP53 Mutations

Christoph Rollig, MD MSC, Jan Moritz Middeke, MD, Sebastian Stasik, Armin Zebisch, MD, Heinz Sill, MD, Michael Kramer, M.Sc., Sebastian Scholl, MD, Andreas Hochhaus, MD, Edgar Jost, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, Hubert Serve, Heidi Altmann, Volker Kunzmann, MD PhD, Hermann Einsele, Stefani Barbara Parmentier, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, MD, Frank Heits, MD, Wolfgang E. Berdel, Katja Sockel, MD, Friedrich Stoelzel, MD, Uwe Platzbecker, MD, Gerhard Ehninger, Martin Bornhäuser, MD, Johannes Schetelig, MD, Christian Thiede, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3896.
https://doi.org/10.1182/blood.V130.Suppl_1.3896.3896
Published: 2017
Journal Articles

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Stefan D Dendorfer, Michael Kramer, M.Sc., Katharina Schmidt-Brücken, Friedrich Stoelzel, MD, Regina Herbst, MD, Richard Noppeney, MD, Zdenek Racil, MD, Jiri Mayer, Prof, MD SCs, Björn Steffen, Tilman Bochtler, MD, Alwin Krämer, MD, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, MD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia D. Baldus, MD, Christoph Schliemann, Martin Kaufmann, MD, Edgar Jost, Ralph Naumann, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Hubert Serve, Wolfgang E. Berdel, Gerhard Ehninger, Martin Bornhäuser, MD, Christoph Rollig, MD MSC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3901.
https://doi.org/10.1182/blood.V130.Suppl_1.3901.3901
Published: 2017
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017
Journal Articles

Excellent Outcome of Elderly Patients with Favourable-Prognosis DLBCL Treated with 4 Cycles CHOP/Chlip-14 Plus 8 Applications of Rituximab and a PET-Based Intensification Strategy That Includes Involved-Site Radiotherapy (IS-RT): Results of the First 120 Patients of the OPTIMAL>60 Trial of the Dshnhl

Michael Pfreundschuh, MD, Niels Murawski, MD, Konstantinos Christofyllakis, Bettina Altmann, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Andreas Neubauer, MD, Gerhard Held, MD, Lorenz Truemper, Christian Schmidt, MD, Lothar Kanz, Kai Huebel, MD, Norbert Schmitz, MD, Tobias Heintges, MD, Heinz Kirchen, MD, Günther Schneider, MD, Christian Ruebe, MD, Christian Berdel, MD, Dirk Hellwig, MD, Jirka Grosse, MD, Viola Poeschel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1549.
https://doi.org/10.1182/blood.V130.Suppl_1.1549.1549
Published: 2017
Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD
Journal: Blood
Blood (2015) 126 (23): 858.
https://doi.org/10.1182/blood.V126.23.858.858
Published: 2015
Journal Articles

Frequency of CTLA-4 Receptor Ligand (CD86, B7.2) -Positive Plasmacytoid Dendritic Cells Predicts Risk of Disease Recurrence after Tyrosine-Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Results from a Prospective Substudy of the Euroski Trial

Andreas Burchert, MD, Sabrina Inselmann, Susanne Saussele, Christian T. Dietz, PhD, Martin C. Müller, MD, Ekkehard Eigendorff, MD, Tim H. Brümmendorf, Prof MD, Cornelius Waller, MD, Jolanta Dengler, MD, Maria Elisabeth Goebeler, MD, Regina Herbst, MD, Gernot Freunek, MD, Stefan Hanzel, MD, Thomas Illmer, MD, Ying Wang, MD, Andreas Neubauer, MD, Thoralf Lange, MD, Andreas Hochhaus, MD, Finkernagel Florian, Cornelia A. Brendel, MD, Joelle Guilhot, PhD, Francois Xavier Mahon, MD PhD, Christin Schütz
Journal: Blood
Blood (2015) 126 (23): 599.
https://doi.org/10.1182/blood.V126.23.599.599
Published: 2015
Journal Articles

Adverse Prognosis in Acute Myeloid Leukemia with Abnormality Abn(3q): Does EVI1 Matter?

Theresa Kretschmann, Christoph Röllig, MD, Brigitte Mohr, Michael Kramer, MSc., Matthias Stelljes, Martin Kaufmann, MD, Kerstin Schäfer-Eckart, Claudia D. Baldus, MD PhD, Alwin Krämer, Hermann Einsele, Mathias Hänel, Regina Herbst, MD, Stefan W. Krause, MD, Andreas Neubauer, MD, Kristina Sohlbach, Martin Bornhäuser, MD, Christian Thiede, MD, Wolfgang E. Berdel, MD, Hubert Serve, MD, Johannes Schetelig, MD M. Sc,, Gerhard Ehninger, MD, Friedrich Stölzel, MD
Journal: Blood
Blood (2015) 126 (23): 1309.
https://doi.org/10.1182/blood.V126.23.1309.1309
Published: 2015
Journal Articles

Antileukemic Activity and Tolerability of ASP2215 80mg and Greater in FLT3 Mutation-Positive Subjects with Relapsed or Refractory Acute Myeloid Leukemia: Results from a Phase 1/2, Open-Label, Dose-Escalation/Dose-Response Study

Jessica K. Altman, MD, Alexander E. Perl, MD, Jorge E. Cortes, MD, Mark J. Levis, MD PhD, Catherine C. Smith, MD, Mark R Litzow, MD, Maria R. Baer, David F. Claxton, MD, Harry P. Erba, MD PhD, Stanley C. Gill, PhD, Stuart L. Goldberg, Joseph G. Jurcic, MD, Richard A. Larson, MD, Charles Lui, PhD, Ellen K Ritchie, MD, Briana Sargent, BS, Gary J Schiller, MD, Alexander I. Spira, MD PhD, Stephen A. Strickland, MD, Raoul Tibes, MD PhD, Celalettin Ustun, MD, Eunice S. Wang, MD, Robert K. Stuart, MD, Claudia D. Baldus, MD PhD, Christoph Rollig, Andreas Neubauer, MD, Giovanni Martinelli, Erkut Bahceci, MD
Journal: Blood
Blood (2015) 126 (23): 321.
https://doi.org/10.1182/blood.V126.23.321.321
Published: 2015
Journal Articles

Maintenance of Respiration Capacity Is an Early Predictor of Drug Resistance in Cancer Cells

Cornelia A Brendel, MD, Katharina Henkenius, Melanie Maerken, Tom Kaiser, Larissa Greif, Stephan Metzelder, MD, Miriam Rehberger, Andreas Neubauer, MD
Journal: Blood
Blood (2014) 124 (21): 2157.
https://doi.org/10.1182/blood.V124.21.2157.2157
Published: 2014
Journal Articles

A Two-Fold Rise of BCR-ABL Transcript Levels Advises BCR-ABL Mutation Analysis in Imatinib-Treated Chronic Myeloid Leukemia (CML) - an Analysis of the Randomized CML-Study IV

Benjamin Hanfstein, MD, Niklas Westhoff, MD, Rüdiger Hehlmann, MD, Susanne Saussele, MD, Michael Lauseker, PhD, Thomas Ernst, MD, Philipp Erben, MD, Christian Dietz, PhD, Alice Fabarius, PhD, Ulrike Proetel, MD, Susanne Schnittger, PhD, Stefan W. Krause, MD, Joerg Schubert, MD, Hermann Einsele, Mathias Hänel, MD, Jolanta Dengler, MD, Christiane Falge, MD, Lothar Kanz, MD, Andreas Neubauer, MD, Michael Kneba, MD, Frank Stegelmann, MD, Michael Pfreundschuh, Cornelius F. Waller, MD, Karsten Spiekermann, MD, Gabriela M. Baerlocher, MD, Markus Pfirrmann, PhD, Joerg Hasford, MD, Wolf-Karsten Hofmann, Andreas Hochhaus, MD, Martin C. Müller, MD
Journal: Blood
Blood (2014) 124 (21): 3138.
https://doi.org/10.1182/blood.V124.21.3138.3138
Published: 2014
Journal Articles

Sorafenib Versus Placebo in Addition to Standard Therapy in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from 267 Patients Treated in the Randomized Placebo-Controlled SAL-Soraml Trial

Christoph Röllig, MD, Carsten Müller-Tidow, MD, Andreas Hüttmann, MD, Richard Noppeney, MD, Volker Kunzmann, MD, Claudia D Baldus, MD, Christian H. Brandts, MD, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Stefan W. Krause, MD, Aristoteles Giagounidis, MD PhD, Walter E. Aulitzky, MD, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani B Parmentier, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD M. Sc,, Michael Kramer, PhD, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD
Journal: Blood
Blood (2014) 124 (21): 6.
https://doi.org/10.1182/blood.V124.21.6.6
Published: 2014
Journal Articles

Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

Carsten Müller-Tidow, MD, Petra Tschanter, MD, Utz Krug, MD, Stefanie Goellner, PhD, Christoph Röllig, MD, Christian Thiede, MD, Anja Koschmieder, Martin Dugas, PhD, Joachim Gerss, PhD, Trude Butterfaß-Bahloul, Ruth Wagner, Stefan W. Krause, MD, Ulrich Kaiser, Volker Kunzmann, MD, Björn Steffen, MD, Richard Noppeney, MD, Wolfgang Herr, MD, Claudia D Baldus, Norbert Schmitz, MD, Katharina Götze, Albrecht Reichle, Martin Kaufmann, MD, Andreas Neubauer, MD, Kerstin Schäfer-Eckart, MD, Mathias Hänel, MD, Rudolf Peceny, MD, Haack Bea, Lilly Meredith, Norbert Frickhofen, MD, Michael G Kiehl, MD, Aristoteles A.N. Giagounidis, MD PhD, Martin Görner, Roland Repp, MD, Ralph Naumann, MD, Hartmut Link, MDPhD, Alexander Kiani, MD, Steffen Koschmieder, MD, Tim H. Brümmendorf, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 946.
https://doi.org/10.1182/blood.V124.21.946.946
Published: 2014
Journal Articles

In Vivo Methylome Changes in Purified Peripheral Blood Blasts and T Cells of AML Patients Treated with Decitabine: Statistical Modelling of a Hypomethylation Response

Nadja Blagitko-Dorfs, PhD, Pascal Schlosser, MSc, Rainer Claus, MD, Tobias Ma, M.Sc., Katharina Götze, Michael Heuser, MD, Gerhard Heil, MD, Sven Wessendorf, MD, Andreas Neubauer, MD, Jürgen Krauter, MD, Irmgard Dresel, MD, Konstanze Döhner, MD, Gesine Bug, Hans Walter Lindemann, MD, Helmut R. Salih, MD, Sebastian Scholl, MD, Carsten Mueller-Tidow, MD, Wolfram Brugger, MD, Olga Grishina, MD, Björn Hackanson, MD, Martin Schumacher, PhD, Michael Lübbert
Journal: Blood
Blood (2014) 124 (21): 870.
https://doi.org/10.1182/blood.V124.21.870.870
Published: 2014